In Vitro Diagnostics Market Growth Factors and Trends to 2018

In Vitro Diagnostics Market (Clinical Chemistry, Immuno assay, Diabetes Testing, Blood Testing, Molecular Diagn ostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

Published By:

Transparency Market Research

Contact US: Tel: +1-518-618-1030 Email: sales@mrrse.com Toll Free : 866-997-4948 (US-CANADA)

ReportÂ Description In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 â&#x20AC;&#x201C; 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report. The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million. Complete Report with TOC @ http://www.mrrse.com/in-vitro-diagnostic-tests-market .

Scope Significant differences in the reimbursement coverage throughout the region and the presence of ambiguous regulatory environment restraints the growth of this market. Although the healthcare system in Europe is better than many parts in the world, the increasing budgetary pressure is curbing the healthcare expenditure in this region. This is resulting into slower growth rate of in vitro diagnostics market in Europe in comparison to that of the Asia-Pacific region. The emergence of molecular diagnostics and the epigenomics-based diagnostics are expected to drive in vitro diagnostics market in Europe. In addition, a trend of diagnostic companies collaborating with pharmaceutical companies to launch companion diagnostics will open a premium segment of in vitro diagnostics market in the near future.

KeyÂ Players The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation. Request a Sample Copy of the Report @ http://www.mrrse.com/sample/332 .